Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review

M Buhl, S Peter, M Willmann - Expert review of anti-infective …, 2015 - Taylor & Francis
Pseudomonas aeruginosa is a Gram-negative human pathogen with extensively drug-
resistant (XDR) strains emerging in hospitals across the globe. This systematic review is …

Clinical Distribution and Drug Resistance of Pseudomonas aeruginosa in Guangzhou, China from 2017 to 2021

J Lyu, H Chen, J Bao, S Liu, Y Chen, X Cui… - Journal of Clinical …, 2023 - mdpi.com
The aim of the current study was to analyse the distribution of antimicrobial drug resistance
(AMR) among Pseudomonas aeruginosa (P. aeruginosa, PA) isolates from Guangdong …

Why new antibiotics are not obviously useful now

G Dubourg, C Abat, D Raoult - International journal of antimicrobial agents, 2017 - Elsevier
For several years, the threat of antibiotic resistance and its health cost has dramatically risen
and various alarming figures have been proposed to illustrate the mortality due to antibiotic …

Extensively drug-resistant Pseudomonas aeruginosa: clinical features and treatment with ceftazidime/avibactam and ceftolozane/tazobactam in a tertiary care …

D Mendes Pedro, SE Paulo, CM Santos… - Frontiers in …, 2024 - frontiersin.org
Introduction Extensively drug-resistant Pseudomonas aeruginosa (XDR-PA) is a growing
concern due to its increasing incidence, limited therapeutic options, limited data on the …

[HTML][HTML] Non-antimicrobial drugs: etodolac as a possible antimicrobial or adjuvant agent against ESKAPE pathogens

SG Pereira, VS Domingues, J Theriága… - The open …, 2018 - ncbi.nlm.nih.gov
Conclusion: Already approved drugs in terms of pharmacokinetics and safety may deploy
faster solutions for antimicrobial therapy against priority pathogens. Current work intends to …

[HTML][HTML] Prevalencia de bacterias aisladas con resistencia antibiótica extendida en los cultivos de orina durante 8 años en un hospital de segundo nivel en México

AJ Chavolla-Canal, MG Gonzalez-Mercado… - Revista Mexicana de …, 2016 - Elsevier
Introducción Las infecciones de vías urinarias ocasionadas por organismos con resistencia
bacteriana extendida se han convertido en un problema importante de salud de difícil …

First Complete Genome Sequence of Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 (DSM 50071T), Determined Using PacBio Single-Molecule Real-Time …

K Nakano, Y Terabayashi, A Shiroma… - Genome …, 2015 - Am Soc Microbiol
The first complete genome sequence of the type strain Pseudomonas aeruginosa (Schroeter
1872) Migula 1900 (DSM 50071T) was determined in a single contig by PacBio RS II. The …

[HTML][HTML] Factores de riesgo asociados con infección de la vía urinaria provocada por superbacterias

AJ Chavolla-Canal… - Revista mexicana de …, 2018 - scielo.org.mx
ANTECEDENTES: En los últimos años ha tomado relevancia la aparición de resistencia
panfarmacológica por superbacterias en pacientes con infección de la vía urinaria. Aunque …

神经内科患者下呼吸道感染抗菌药物利用研究

刘坤, 宫建, 杨静, 于嵩 - 中国公共卫生, 2017 - zgggws.com
目的探讨神经内科下呼吸道感染住院患者的抗菌药物利用情况, 促进患者的合理用药.
方法自辽宁省两城市4 家三级甲等医院随机选取2014 年1 月1 日—2016 年1 月1 …

[PDF][PDF] Drugs-resistant Pseudomonas aeruginosa isolated from various clinical specimens in Khartoum, Sudan

MA Yagoup, AA Taha, AK Mubarak, A ELGAILI… - Children, 2019 - researchgate.net
Aim: To identify the drug resistance phenotypes of clinical Ps. aeruginosa isolates from
various clinical samples in Khartoum state, Sudan. Methods: This cross-sectional study was …